Daniels S B, Katzenellenbogen J A
Biochemistry. 1986 Mar 25;25(6):1436-44. doi: 10.1021/bi00354a037.
In a previous investigation [Daniels, S. B., Cooney, E., Sofia, M. J., Chakravarty, P. K., & Katzenellenbogen, J. A. (1983) J. Biol. Chem. 258, 15046-15053], we demonstrated that alpha-aryl-substituted five- and six-membered ring halo enol lactones were effective inhibitors of chymotrypsin, and we proposed that they reacted by an enzyme-activated mechanism: acyl transfer to the active site serine generates a halomethyl ketone that remains tethered in the catalytic site until it alkylates an accessible nucleophilic residue. In this study, we have investigated in greater detail the process of chymotrypsin inactivation by an alpha-naphthyl-substituted five- and six-membered bromo enol lactone. Inactivation by both compounds appears to be active site directed, since the time-dependent inactivation is retarded by competing substrate. The possible involvement of a paracatalytic mechanism for inactivation (generation of a free, rather than active site bound, inactivating species) was investigated by comparing the inactivation efficiencies of the lactones with that of the bromomethyl keto acid hydrolysis products. The bromomethyl ketone derived from the five-membered lactone is ineffective, whereas that derived from the six-membered lactone is highly efficient. However, the possible involvement of the free keto acid in chymotrypsin inactivation by the six-membered lactone is ruled out by experiments involving selective scavenging. The long-term inactivation of chymotrypsin requires the presence of the bromine substituent and appears to involve an alkylation rather than an acylation reaction (hydrazine resistant). Furthermore, a 1:1 lactone:enzyme stoichiometry is demonstrated with the 14C-labeled six-membered lactone. These results are consistent with the mechanism-based inactivation process previously presented.
在先前的一项研究中[丹尼尔斯,S. B.,库尼,E.,索菲亚,M. J.,查克拉瓦蒂,P. K.,& 卡曾内伦博根,J. A.(1983年)《生物化学杂志》258卷,第15046 - 15053页],我们证明了α - 芳基取代的五元环和六元环卤代烯醇内酯是胰凝乳蛋白酶的有效抑制剂,并且我们提出它们通过酶激活机制起反应:酰基转移到活性位点丝氨酸上生成一个卤代甲基酮,该卤代甲基酮一直束缚在催化位点,直到它烷基化一个可及的亲核残基。在本研究中,我们更详细地研究了α - 萘基取代的五元环和六元环溴代烯醇内酯使胰凝乳蛋白酶失活的过程。两种化合物的失活似乎都是活性位点导向的,因为时间依赖性失活受到竞争性底物的抑制。通过比较内酯与溴甲基酮酸水解产物的失活效率,研究了失活过程中副催化机制(生成游离的而非结合在活性位点的失活物种)的可能参与情况。五元环内酯衍生的溴甲基酮无效,而六元环内酯衍生的溴甲基酮则非常有效。然而,通过选择性清除实验排除了游离酮酸参与六元环内酯使胰凝乳蛋白酶失活的可能性。胰凝乳蛋白酶的长期失活需要溴取代基的存在,并且似乎涉及烷基化而非酰化反应(抗肼)。此外,用14C标记的六元环内酯证明了内酯与酶的化学计量比为1:1。这些结果与先前提出的基于机制的失活过程一致。